Theoretical Considerations for Direct Translation of Unbound Liver-to-Plasma Partition Coefficient from In Vitro to In Vivo
暂无分享,去创建一个
[1] Yuan Chen,et al. Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling , 2018, CPT: pharmacometrics & systems pharmacology.
[2] L. Di,et al. Novel Method to Predict In Vivo Liver-to-Plasma Kpuu for OATP Substrates Using Suspension Hepatocytes , 2017, Drug Metabolism and Disposition.
[3] T. Kietzmann. Metabolic zonation of the liver: The oxygen gradient revisited , 2017, Redox biology.
[4] L. Di,et al. Determination of Unbound Partition Coefficient and in Vitro–in Vivo Extrapolation for SLC13A Transporter–Mediated Uptake , 2016, Drug Metabolism and Disposition.
[5] W. Humphreys,et al. Rosuvastatin Liver Partitioning in Cynomolgus Monkeys: Measurement In Vivo and Prediction Using In Vitro Monkey Hepatocyte Uptake , 2015, Drug Metabolism and Disposition.
[6] Aleksandra Galetin,et al. Meta-Analysis of Expression of Hepatic Organic Anion–Transporting Polypeptide (OATP) Transporters in Cellular Systems Relative to Human Liver Tissue , 2015, Drug Metabolism and Disposition.
[7] Jörg Huwyler,et al. The extended clearance model and its use for the interpretation of hepatobiliary elimination data , 2015 .
[8] J. Huwyler,et al. Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data , 2014, Drug Metabolism and Disposition.
[9] Hugh A. Barton,et al. A “middle-out” approach to human pharmacokinetic predictions for OATP substrates using physiologically-based pharmacokinetic modeling , 2014, Journal of Pharmacokinetics and Pharmacodynamics.
[10] T. Andersson,et al. Prediction of In Vivo Rat Biliary Drug Clearance from an In Vitro Hepatocyte Efflux Model , 2014, Drug Metabolism and Disposition.
[11] T. Andersson,et al. Functional ATP-Binding Cassette Drug Efflux Transporters in Isolated Human and Rat Hepatocytes Significantly Affect Assessment of Drug Disposition , 2014, Drug Metabolism and Disposition.
[12] Per Artursson,et al. Rapid measurement of intracellular unbound drug concentrations. , 2013, Molecular pharmaceutics.
[13] E. van de Steeg,et al. Murine Oatp1a/1b Uptake Transporters Control Rosuvastatin Systemic Exposure Without Affecting Its Apparent Liver Exposure , 2013, Molecular Pharmacology.
[14] Chuang Lu,et al. Preclinical experimental models of drug metabolism and disposition in drug discovery and development , 2012 .
[15] Hugh A. Barton,et al. Mechanistic Pharmacokinetic Modeling for the Prediction of Transporter-Mediated Disposition in Humans from Sandwich Culture Human Hepatocyte Data , 2012, Drug Metabolism and Disposition.
[16] A. Galetin,et al. Kinetic Characterization of Rat Hepatic Uptake of 16 Actively Transported Drugs , 2011, Drug Metabolism and Disposition.
[17] Meng Li,et al. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] K. Brouwer,et al. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes , 2008, Drug Metabolism and Disposition.
[19] Yuichi Sugiyama,et al. Transporters as a determinant of drug clearance and tissue distribution. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[20] H. Teutsch. The modular microarchitecture of human liver , 2005, Hepatology.
[21] Kiyomi Ito,et al. Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated Hepatocytes , 2004, Pharmaceutical Research.
[22] Paul D. Martin,et al. Absolute oral bioavailability of rosuvastatin in healthy white adult male volunteers. , 2003, Clinical therapeutics.
[23] M. Yamazaki,et al. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats. , 1996, Biopharmaceutics & drug disposition.
[24] Malcolm Rowland,et al. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance , 1977, Journal of Pharmacokinetics and Biopharmaceutics.
[25] Kazuya Maeda,et al. Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. , 2013, Biopharmaceutics & drug disposition.